Tramadol for Labor Analgesia: a Placebo Controlled Randomised Control Trial
Primary Purpose
Tramadol for Labor Analgesia
Status
Unknown status
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Tramadol Hydrochloride
Distilled Water
Sponsored by
About this trial
This is an interventional treatment trial for Tramadol for Labor Analgesia
Eligibility Criteria
Inclusion Criteria:
- delivering for first time(nulliparous)
- well established labor ( 3 or more contractions in a span of ten minutes
- cervical dilation of 4 cm or more
- >= 80% effacement of cervix
Exclusion Criteria:
- any medical disorder- diabetes,hypertension
- obstetric high risk factors
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
tramadol
distilled water
Arm Description
50mg tramadol hydrochloride will be used intramuscularly as an experimental drug for evaluating its safety and efficacy as labor analgesic
2ml distilled water intramuscularly will be used as a placebo.
Outcomes
Primary Outcome Measures
visual analogue scale
visual analogue scale i.e scaling of severity of pain from 1 being mildest and 10 being most severe will be assessed at 2nd hour of administration
Secondary Outcome Measures
patient satisfaction
scale of 1-5 including highly satisfied, moderately satisfied ,it is ok ,not satisfied ,highly unsatisfied
fetal distress
fetal tachycardia (heart rate more than 160) or fetal bradycardia (heart rate less than 100)
duration of 1st and 2nd stage of labor
women with side effects like postpartum haemorrhage, nausea, vomiting and increased sleepiness
increased risk of postpartum haemorrhage, nausea , vomiting and sleepiness may be associated with use of tramadol
neonatal safety in terms of apgar score and nicu admission
need for caesarean section or instrumental delivery
emergency caesarean section or need for forceps or vacuum application
Full Information
NCT ID
NCT02999594
First Posted
December 2, 2016
Last Updated
December 22, 2016
Sponsor
Maulana Azad Medical College
1. Study Identification
Unique Protocol Identification Number
NCT02999594
Brief Title
Tramadol for Labor Analgesia: a Placebo Controlled Randomised Control Trial
Official Title
Tramadol for Labor Analgesia in Low Risk Women: A Placebo Controlled Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2016
Overall Recruitment Status
Unknown status
Study Start Date
December 2016 (undefined)
Primary Completion Date
April 2018 (Anticipated)
Study Completion Date
May 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Maulana Azad Medical College
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Tramadol for labor analgesia: a low risk placebo controlled randomised control trial
Detailed Description
Investigators will administer 100mg tramadol or 2ml distilled water through intramuscular route in a blinded manner. Visual analogue score will be assessed in the beginning and every hour till four hours. patient satisfaction, safety outcomes, duration of 1st and 2nd stage of labor, proportion of women experiencing nausea, vomiting and increased sleepiness, postpartum haemorrhage,apgar score at 5 minute, need for nicu admission wiil be assessed at the end
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tramadol for Labor Analgesia
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
86 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
tramadol
Arm Type
Experimental
Arm Description
50mg tramadol hydrochloride will be used intramuscularly as an experimental drug for evaluating its safety and efficacy as labor analgesic
Arm Title
distilled water
Arm Type
Placebo Comparator
Arm Description
2ml distilled water intramuscularly will be used as a placebo.
Intervention Type
Drug
Intervention Name(s)
Tramadol Hydrochloride
Intervention Description
50mg intramuscularly
Intervention Type
Drug
Intervention Name(s)
Distilled Water
Intervention Description
2ml intramuscularly
Primary Outcome Measure Information:
Title
visual analogue scale
Description
visual analogue scale i.e scaling of severity of pain from 1 being mildest and 10 being most severe will be assessed at 2nd hour of administration
Time Frame
at 2nd hour of administration
Secondary Outcome Measure Information:
Title
patient satisfaction
Description
scale of 1-5 including highly satisfied, moderately satisfied ,it is ok ,not satisfied ,highly unsatisfied
Time Frame
at the end of labor( within 12 hours)
Title
fetal distress
Description
fetal tachycardia (heart rate more than 160) or fetal bradycardia (heart rate less than 100)
Time Frame
during labor
Title
duration of 1st and 2nd stage of labor
Time Frame
1st and 2nd stage
Title
women with side effects like postpartum haemorrhage, nausea, vomiting and increased sleepiness
Description
increased risk of postpartum haemorrhage, nausea , vomiting and sleepiness may be associated with use of tramadol
Time Frame
till the end of labor
Title
neonatal safety in terms of apgar score and nicu admission
Time Frame
apgar score at 0 and 5 min
Title
need for caesarean section or instrumental delivery
Description
emergency caesarean section or need for forceps or vacuum application
Time Frame
during labor
10. Eligibility
Sex
Female
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
delivering for first time(nulliparous)
well established labor ( 3 or more contractions in a span of ten minutes
cervical dilation of 4 cm or more
>= 80% effacement of cervix
Exclusion Criteria:
any medical disorder- diabetes,hypertension
obstetric high risk factors
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
dr aastha raheja
Phone
8586032882
Email
aastha_raheja2000@yahoo.com
First Name & Middle Initial & Last Name or Official Title & Degree
dr krishna agarwal
Phone
9871214208
Email
drkrishna.agarwal@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
dr aastha raheja
Organizational Affiliation
Maulana Azad Medical College
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Tramadol for Labor Analgesia: a Placebo Controlled Randomised Control Trial
We'll reach out to this number within 24 hrs